Erythema nodosum and erythema induratum (nodular vasculitis): Diagnosis and management

Dermatologic Therapy

Volumn 23, Issue 4, 2010, Pages 320-327

  Gilchrist, Heidi ^a   Patterson, James W ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

erythema induratum; erythema nodosum; management; nodular vasculitis; treatment

Indexed keywords

ACETYLSALICYLIC ACID; CABERGOLINE; CELECOXIB; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; DICLOFENAC; ESTROGEN; GOLD COMPLEX; GRANULOCYTE COLONY STIMULATING FACTOR; HALOGEN; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; INFLIXIMAB; KETOPROFEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; ORAL CONTRACEPTIVE AGENT; PENICILLIN G; POTASSIUM IODIDE; SALSALATE; SULFONAMIDE; SULINDAC; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; BED REST; BONE MARROW SUPPRESSION; BULLOUS PEMPHIGOID; CROHN DISEASE; DERMATITIS HERPETIFORMIS; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSGEUSIA; ERUCTATION; ERYTHEMA NODOSUM; FUSARIUM; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; HEART DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LUNG EDEMA; LYMPHADENOPATHY; METABOLIC ACIDOSIS; MYALGIA; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NOCARDIA; NONHUMAN; PANCREATITIS; PANCYTOPENIA; PATHOGENESIS; POLYARTERITIS NODOSA; PSEUDOMONAS; PUSTULAR PSORIASIS; REVIEW; RISK BENEFIT ANALYSIS; SALIVATION; SARCOIDOSIS; SEX RATIO; SIDE EFFECT; SKIN TUBERCULOSIS; TUBERCULIN TEST; URTICARIA; VASCULITIS; ERYTHEMA INDURATUM; INFLAMMATION; PATHOPHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTITUBERCULAR AGENTS; COLCHICINE; ERYTHEMA INDURATUM; ERYTHEMA NODOSUM; HUMANS; INFLAMMATION; POTASSIUM IODIDE;

EID: 77955042059     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01332.x     Document Type: Review

References (66)

1. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 1998 : 37 : 667 672.
2. Garcia-Porrua C, González-Gay MA, Vázquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factorsin a defined population. Arthritis Rheum 2000 : 43 : 584 592.
3. White WL, Hitchcock MG. Diagnosis: erythema nodosum or not? Semin Cutan Med Surg 1999 : 18 : 47 55.
4. Requena L, Sanchez Yus E. Erythema nodosum. Semin Cutan Med Surg 2007 : 26 : 114 125.
5. Bafverstedt B. Erythema nodosum migrans. Acta Derm Venereol 1954 : 34 : 181 193.
6. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis 2004 : 36 : 424 427.
7. Requena L, Sanchez Yus E. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol 2001 : 45 : 163 183.
8. Gordon H. Erythema nodosum: a review of one hundred and fifteen cases. Br J Dermatol 1961 : 73 : 393 409.
9. Forstrom L, Winkelman RK. Acute panniculitis: a clinical and histological study of 34 cases. Arch Dermatol 1977 : 183 : 909 917.
10. Kakourou T, Drosatou P, Psychou F, Aroni K, Nicolaidou P. Erythema nodosum in children: a prospective study. J Am Acad Dermatol 2001 : 44 : 17 21.
11. Lin JT, Chen PM, Huang DF, Kwang WK, Lo K, Wang WS. Erythema nodosum associated with carcinoid tumour. Clin Exp Dermatol 2004 : 29 : 426 427.
12. Durden FM, Variyam E, Chren MM. Fat necrosis with features of erythema nodosum in a patient with metastatic pancreatic carcinoma. Int J Dermatol 1996 : 35 : 39 41.
13. Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician 2007 : 75 : 695 700.
14. Arsura EL, Kilgore WB, Ratnayake SN. Erythema nodosum in pregnant patients with coccidioidomycosis. Clin Infect Dis 1998 : 27 : 1201 1203.
15. Senturk T, Aydintug O, Kuzu I, et al. Adhesion molecule expression in erythema nodosum-like lesions in Behcet's disease. A histopathological and immunohistochemical study. Rheumatol Int 1998 : 18 : 51 57.
16. Kunz M, Beutel S, Brocker E. Leukocyte activation in erythema nodosum. Clin Exp Dermatol 1999 : 24 : 396 401.
17. Llorente L, Richaud-Patin Y, Alvarado C, et al. Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum. Eur Cytokine Netw 1997 : 8 : 67 71.
18. Labunski S, Posern G, Ludwig S, Kundt G, Brocker EB, Kunz M. Tumor necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001 : 81 : 18 21.
19. Mert A, Kumbasar H, Ozaras R, et al. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rhematol 2007 : 25 : 563 570.
20. Tremaine WJ. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD. Inflamm Bowel Dis 1998 : 4 : 68 69, 73.
21. Jankovic SM, Aleksic J, Rakovic S, et al. Nonsteroidal anti-inflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis. J Nephrol 2009 : 22 : 502 507.
22. Baron JA, Sandler RS, Bresalier RS, et al. Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 2008 : 372 : 1756 1764.
23. Damase-Michel C, Christaud J, Berrebi A, Lacroix I, Montastruc JL. What do pregnant women know about non-steroidal anti-inflammatory drugs? Pharmacoepidemiol Drug Saf 2009 : 18 : 1034 1038.
24. Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century - uses, pharmacology, adverse affects, and contraindications. J Am Acad Dermatol 2000 : 43 : 691 697.
25. Honma K, Saga K, Onodera H, Takahashi M. Potassium iodide inhibits neutrophil chemotaxis. Acta Derm Venereol 1990 : 70 : 247 249.
26. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicines, and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 1982 : 107 : 209 214.
27. Torinuki W. Wegener's granulomatosis successfully treated with prednisolone and potassium iodide. J Dermatol 1994 : 21 : 693 695.
28. Giessel M, Graves K, Kalivas J. Treatment of disseminated granuloma annulare with potassium iodide. Arch Dermatol 1979 : 115 : 639 640.
29. Caserio RJ, Eaglstein WH, Allen CM. Treatment of granuloma annulare with potassium iodide. J Am Acad Dermatol 1984 : 10 : 294 295.
30. Mercurio MG, Elewski BE. Therapy for sporotrichosis. Semin Dermatol 1993 : 12 : 285 289.
31. Cabezas C, Bustamante B, Holgado W, Begue R. Treatment of cutaneous sporotrichosis with once daily dose of potassium iodide. Pediatr Infect Dis 1996 : 15 : 352 354.
32. http://www.upsher-smith.com/PDFs/SSKI-PI.pdf.
33. Horio T, Imamura S, Danno K, et al. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol 1981 : 117 : 29 31.
34. Cohen PR, Holder WR, Rapini RP. Concurrent Sweet's syndrome and erythema nodosum: a report, world literature review and mechanism of pathogenesis. J Rheumatol 1992 : 19 : 814 820.
35. Jubiz W, Carlile S, Lagerquist LD. Serum thyrotropin and thyroid hormone levels in humans receiving chronic potassium iodide. J Clin Endocrinol Metab 1997 : 44 : 379 382.
36. Haung TY, Peterson GH. Pulmonary edema and iododerma induced by potassium iodide in the treatment of asthma. Ann Allergy 1981 : 46 : 264 266.
37. Delk C, Holstege CP, Brady WJ. Electrocardiographic abnormalities associated with poisoning. Am J Emerg Med 2007 : 25 : 672 687.
38. Yurdakul S, Mat C, Tuzun Y, et al. A double-blind trial of colchicines in Behcet's syndrome. Arthritis Rheum 2001 : 44 : 2686 2692.
39. Molad Y. Update on colchicines and its mechanism of action. Curr Rheumatol Rep 2002 : 4 : 252 256.
40. Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 2008 : 10 : 218 227.
41. Harris R, Marx G, Gillett M, Kark A, Arunanthy S. Colchicine-induced bone marrow suppression: treatment with granulocyte colony-stimulating factor. J Emerg Med 2000 : 18 : 435 440.
42. Siemanowski B, Regueiro M. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease. Curr Treat Options Gastroenterol 2007 : 10 : 178 184. (Pubitemid 46938927)
43. Clayton TH, Walker BP, Stables GI. Treatment of chronic erythema nodosum with infliximab. Clin Exp Dermatol 2006 : 31 : 823 824.
44. Rosen T, Martinelli P. Erythema nodosum associated with infliximab therapy. Dermatol Online J 2008 : 14 : 3.
45. Delle Sedie A, Bazzichi L, Bombardieri S, Riente L. Psoriasis, erythema nodosum, and nummular eczema onset in an ankylosing spondylitis patient treated with infliximab. Scand J Rhematol 2007 : 36 : 403 404.
46. Alloway JA, Franks LK. Hydroxychloroquine in the treatment of chronic erythema nodosum. Br J Dermatol 1995 : 132 : 661 662.
47. Jarrett P, Goodfield MJ. Hydroxychloroquine and chronic erythema nodosum. Br J Dermatol 1996 : 134 : 373.
48. Cribier E, Grosshans E. Bazin's erythema induratum: obsolete concept and terminology. Ann Dermatol Venereol 1990 : 117 : 937 943.
49. Cho KH, Lee DY, Kim CW. Erythema induratum of Bazin. Int J Dermatol 1996 : 35 : 802 808.
50. Segura S, Pujol RM, Trindade F, et al. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol 2008 : 59 : 839 851.
51. Schneider JW, Jordaan HF. The histopathologic spectrum of erythema induratum of Bazin. Am J Dermatopathol 1997 : 19 : 323 333.
52. Degitz K, Messer G, Schirren H, et al. Successful treatment of erythema induratum of Bazin following rapid detection of mycobacterial DNA by polymerase chain reaction [letter]. Arch Dermatol 1993 : 129 : 1619 1620.
53. Schneider JW, Jordaan HF, Geiger DH, et al. Erythema induratum of Bazin. A clinicopathologic study of 20 cases and detection of Mycobacterium tuberculosis DNA in skin lesions by polymerase chain reaction. Am J Dermatopathol 1995 : 17 : 350 356.
54. Chuang YH, Kuo TT, Wang CM, et al. Simultaneous occurrence of papulonecrotic tuberculid and erythema induratum and the identification of Mycobacterium tuberculosis DNA by polymerase chain reaction. Br J Dermatol 1997 : 137 : 276 281.
55. Baselga E, Margall N, Barnadas MA, et al. Detection of Mycobacterium tuberculosis DNA in lobular granulomatous panniculitis (erythema induratum-nodular vasculitis). Arch Dermatol 1997 : 133 : 457 462.
56. Patterson JW, Brown PC, Broecker AH. Infection-induced panniculitis. J Cutan Pathol 1989 : 16 : 183 193.
57. Gimenez-Garcia R, Sanchez-Ramon S, Sanchez-Antolin G. Red fingers syndrome in recurrent panniculitis in a patient with chronic hepatitis C. J Eur Acad Dermatol Venereol 2003 : 17 : 692 694.
58. Wolf D, Ben-Yehuda A, Okon E, et al. Nodular vasculitis associated with propylthiouracil therapy. Cutis 1992 : 49 : 253 255.
59. Ollert MW, Thomas P, Korting HC. Erythema induratum of Bazin. Evidence of T-lymphocyte hyperresponsiveness to purified protein derivative of tuberculin: report of two cases and treatment. Arch Dermatol 1993 : 129 : 469 473.
60. Lighter J, Tse TB, Li Y, et al. Erythema induratum of Bazin in a child: evidence for a cell-mediated hyper-response to Mycobacterium tuberculosis. Pediatr Infect Dis J 2009 : 28 : 326 328.
61. Angus J, Roberts C, Kulkarni K. Usefulness of the QuantiFERON test in the confirmation of latent tuberculosis in association with erythema induratum. Br J Dermatol 2007 : 157 : 1293 1294.
62. Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 2001 : 45 : 325 361.
63. Schulz EJ, Whiting DA. Treatment of erythema nodosum and nodular vasculitis with potassium iodide. Br J Dermatol 1976 : 94 : 75 78.
64. Hoti H, Imamura S, Danno K, et al. Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol 1981 : 117 : 29 31.
65. Taverna JA, Radfar A, Pentland A, et al. Case reports: nodular vasculitis responsive to mycophenolate mofetil. J Drugs Dermatol 2006 : 5 : 992 993.
66. Shaffer N, Kerdel FA. Nodular vasculitis (erythema induratum): treatment with auranofin. J Am Acad Dermatol 1991 : 25 : 426 429.